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INTRODUCTION
Ischemic colitis (IC) is the most common form of bowel 
ischemia and occurs with greater frequency in the elderly. 
There are various clinical symptoms of ischemic colitis and 
the most common symptoms include abdominal pain, he-
matochezia and diarrhea.
1 IC is occurred with risk factors 
such as hypertension, diabetes mellitus (DM), coronary heart 
disease, congestive heart disease, hyperlipidemia and vasoac-
tive medicine history, but these are not established yet since 
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risk factors are hard to confirm in most cases.
2,3 IC is diag-
nosed by combining clinical, biochemical, radiological, colo-
noscopic, and pathologic findings since the symptoms of IC 
are not specific and there is no specific examination for IC 
diagnosis.
4 Most non-necrotic IC could be improved without 
special complication by conservative treatment consisting of 
dehydration correction, drugs that contract mesenteric ves-
sels and extensive antibiotics together with fasting.
5 Full-
thickness necrotic IC or ischemia of the whole colon, howev-
er, often requires surgical treatment in addition to medical 
treatment. Mortality of such cases is reported between 29% 
and 75% despite aggressive medical or surgical treatment.
6,7 
It is very important, therefore, to identify prognostic factors 
that can predict adverse outcomes and to perform initial 
screening in patients who are expected to show poor prog-
nosis, before deciding treatment modality. This study per-
formed a comparative analysis between medical treatment 
and surgical treatment in IC patients to evaluate differences 
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from baseline clinical characteristics.
MATERIALS AND METHODS 
Patients
Between May 2001 and April 2010, we performed a retro-
spective analysis in 81 patients who were diagnosed as IC in 
Chonnam National University Hospital. Patients with acute 
presentation of symptoms such as abdominal pain and he-
matochezia but without history of inflammatory bowel dis-
eases including ulcerative colitis or Crohn’s disease and med-
ication history such as antibiotics immediately before sym- 
ptom presentation and negative stool culture result were di-
agnosed as IC when reasonable by colonoscopy or abdomi-
nal computed tomography (CT). Patients were classified into 
two groups; medical treatment group and surgical treatment 
group. Medical treatment group was defined as patients who 
received conservative treatment only, and surgical treatment 
group as patients who received surgical treatment (n=18) or 
patients whose family refused scheduled surgery due to un-
derlying disease or old age (n=3). 
Methods
In this retrospective analysis, we compared the patients 
enrolled in medical treatment group and surgical treatment 
group by their age, gender, underlying medical illness, symp-
tom, physical examination, colonoscopy, treatment and clini-
cal course based on medical records. IC was diagnosed when 
there is agreement between colonoscopist’s description of 
finding and another gastroenterologists’ opinion, and ab-
dominal CT was analyzed based on an experienced radiolo-
gist’s reading. Colon was categorized and characterized as 
right colon (proximal portion of the splenic flexure) involve-
ment, left colon (distal portion of the splenic flexure) in-
volvement, or whole colon involvement. 
Statistical analysis
SPSS version 18.0 (SPSS Inc., Chicago, IL, USA) was used 
for statistical analysis. Chi-square test and Mann-Whitney U 
test was performed for between-group analysis. Multiple re-
gression analysis using stepwise variable selection was per-
formed to find clinical factors that influence treatment mo-
dality and their influences. A p-value less than 0.05 was 
determined significant. 
RESULTS
Clinical characteristics of enrolled patients
Overall 81 patients were diagnosed as IC. Mean age of 
these patients were 64.09±14.42 years old. Thirty-six (44.4%) 
were male and 45 (55.6%) were female patients. The most 
common underlying medical illness were hypertension 
(n=24, 29.6%) and DM (n=17, 21.0%), followed by coronary 
artery disease, liver cirrhosis and cerebrovascular disease 
(n=5, 6.2% each), congestive heart failure (n=2, 2.5%), and 
end-stage renal disease (ESRD; n=1). The most common 
symptoms were abdominal pain (n=61, 75.3%) followed by 
hematochezia (n=43, 53.1%), diarrhea (n=29, 35.8%), and 
vomiting (n=11, 13.6%). The median time to admission after 
symptom presentation was 3.53±6.34 days. IC was diag-
nosed, in addition to clinical symptoms, by barium study, 
colonoscopy, and abdominal CT in 3 (3.7%), 56 (69.1%), and 
56 (69.1%) patients, respectively. Left colon was most com-
monly involved (41 cases, 50.6%) followed by right colon (32 
cases, 39.5%) and whole colon (8 cases, 9.9%). At admission, 
patients showed abdominal tenderness (n=40, 49.4%) or ab-
dominal rebound tenderness (n=18, 22.2%) at physical ex-
amination, and leukocytosis (leukocyte count ≥10,000/L; 
n=40, 49.4%), serum creatinine elevation (serum Cr >1.2 
mg/dL; n=23, 28.4%), or C-reactive protein (CRP) elevation 
above 1 mg/dL (n=58, 71.6%) were reported at laboratory 
findings. Seventy patients (86.4%) were recovered after treat-
ment; 11 patients (13.6%) died (Tables 1, 2). 
Comparison of clinical characteristics according to 
treatment
Among 81 patients diagnosed as IC, 60 patients received 
medical treatment and 21 patients received surgical treat-
ment. The mean age of medical treatment group was 62.47± 
15.10 years old, 27 (45.0%) were male and 33 (55.0%) were 
female patients. The mean age of surgical treatment group 
was 68.71±11.36 years old, 9 (42.9%) were male and 12 (7.1%) 
were female patients. There was no significant difference in 
mean age and gender ratio between the groups (Table 1).
Vomiting (5.9% vs. 38.1%, p<0.01), abdominal tenderness 
(45.1% vs. 81.0%, p<0.01), and abdominal rebound tender-
ness (7.8% vs. 66.7%) were more common as initial symp-
toms in surgical treatment group; hematochezia (53.1% vs. 
63.3%, p=0.02) was more common in medical treatment 
group. With regard to vital signs at admission, significantly 
more patients at surgical treatment group showed heart rate 
over 90 beats/min (5.0% vs. 23.8%, p=0.02) or systolic blood 
pressure less than 100 mm Hg (8.3% vs. 33.3%, p=0.01). 
With regard to laboratory findings, serum Na
+ was signifi-
cantly higher in medical treatment group (p=0.02), and se-
rum lactate dehydrogenase (LDH) and CRP were signifi-
cantly higher in surgical treatment group (both p<0.01). 
Significantly more patients in surgical treatment group sho-
wed hyponatremia (serum Na
+ level less than lower normal 
range; 11.6% vs. 38.1%, p=0.01) or LDH level above upper 
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normal range (5.0% vs. 42.8%, p<0.01); there was no signifi-
cant difference in the number of patients whose CRP level 
increased above upper normal range (1 mg/dL) between the 
two groups (p=0.08). Unlike CRP, the absolute value of se-
rum creatinine level was not significantly different between 
the groups; significantly more patients in surgical treatment 
group showed increased serum creatinine level above the up-
per normal range (1.2 mg/dL) than in medical treatment 
group (21.6% vs. 47.6%, p=0.04). A total of 98.3% of patients 
recovered in the medical treatment group, while only 52.4% 
recovered in the surgical treatment group with 47.6% of 
mortality. Other factors such as age, gender, underlying 
medical illness, colonic involvement site, and laboratory 
findings at admission did not show any difference between 
the groups (Tables 2, 3).
Clinical factor analysis associated with surgical  
treatment
We could not find a significant factor associated with sur-
gical treatment by multivariate regression analysis determin-
ing clinical factors requiring surgical treatment than medical 
treatment. Abdominal rebound tenderness, however, was 
found as the most important clinical factor associated with 
surgical treatment (relative risk, 23.50).
Table 1. Clinical Characteristics of the Patients with Ischemic Colitis
All
(n=81)
Medical
treatment group
(n=60)
Surgical 
treatment group
(n=21)
p-value
a)
Age, mean±SD, yr 64.09±14.40 62.47±15.10  68.71±11.36  0.11
Male, No. (%)  36 (44.4) 27 (45.0)  009 (42.9)  0.87 
Underlying medical illness, No. (%)
Hypertension  24 (29.6) 19 (31.7)  005 (23.8)  0.50
Diabetes mellitus  17 (21.0) 12 (20.0)  005 (23.8)  0.71 
Coronary heart disease  05 (6.2) 04 (6.7)  001 (4.8)  0.76 
Congestive heart failure  02 (2.5) 01 (1.7)  001 (4.8)  0.43 
Liver cirrhosis  05 (6.2) 05 (8.3)  001 (1.7)  0.18 
ESRD  01 (1.2) 01 (1.7)  001 (1.7)  0.55 
Old CVA  05 (6.2) 04 (6.7)  001 (4.8)  0.76
Diagnosis modality, No. (%) 
Barium study  03 (3.7) 03 (5.0)  000 (0)  0.30 
Colonoscopy  56 (69.1) 51 (85.0)  005 (8.9)  <0.01 
Abdominal CT  56 (69.1) 35 (61.4)  021 (100)  <0.01
Initial symptom, No. (%) 
Abdominal pain  61 (75.3) 42 (70.0)  19 (90.5)  0.06 
Hematochezia  43 (53.1) 38 (63.3)  05 (23.8)  <0.01
Diarrhea  29 (35.8) 22 (36.7)  07 (33.3)  0.78 
Vomiting  11 (13.6) 03 (5.9)  08 (38.1)  <0.01
Abdominal tenderness  40 (49.4) 23 (45.1)  17 (81.0)  <0.01
Abdominal rebound tenderness  18 (22.2) 04 (7.8)  14 (66.7)  <0.01
Constipation  07 (8.6) 05 (8.3)  02 (9.5)  0.87 
Involvement, No. (%)  0.22
Whole colon  05 (6.2) 02 (3.8)  03 (14.3) 
Right sided colon  30 (37.0) 21 (39.6)  09 (42.9) 
Left sided colon  39 (48.1) 30 (56.6)  09 (42.9) 
Clinical outcome, No. (%)  <0.01
Recovery  70 (86.4) 59 (98.3)  11 (52.4) 
Death (or transfer)  11 (13.6) 01 (1.7)  10 (47.6) 
SD, standard deviation; ESRD, end stage renal disease; CVA, cerebrovascular accident; CT, computed tomography.
a)p-value was calculated by chi-square test and Mann-Whitney U test.
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DISCUSSION
IC is the most common bowel ischemic disease without 
specific symptom or diagnostic tool, which is why medical 
doctors’ aggressive diagnostic course and doubt is important 
to clarify the incidence rate of IC in general population. The 
incidence rate of IC at the moment is reported roughly 
around 6.1 to 47 cases per 100,000 person-years in literature.
8 
IC has various clinical courses from recovering with medi-
cal treatment to requiring surgical treatment due to full-
thickness colon necrosis.
9 The initial course to find an appro-
priate treatment is to identify clinical, biochemical, colono- 
scopic or radiologic factors for screening of patient group 
who requires more aggressive treatment such as surgery 
rather than medical treatment. There is only a few studies, 
however, investigating this issue. This study was performed 
to find difference in clinical factors between medical and 
surgical treatment group in IC patients.
IC is well-known to occur mostly in elderly people. The 
mean age of IC patients was reported, in some studies, to be 
Table 2. Clinical Presentations at Admission (I)
All
(n=81)
Medical 
treatment group
(n=60)
Surgical 
treatment group
(n=21)
p-value
a)
Symptom duration, day 03.53±6.34 09.85±29.7 1.83±2.45 0.07
Hear rate, min 80.44±13.35 78.19±11.21 86.30±16.70 0.02
SBP, mm Hg 123.80±21.79 128.55±18.81 106.30±33.04 <0.01
WBC, /mm
3 11,490.92±7,010.57 10,942.73±5,320.89 12,926.67±10,240.73 0.74
Hb, g/dL 12.70±2.45 12.80±2.30 12.21±2.70 0.21
s-Cr, mg/dL 01.25±0.94 1.153±0.89 1.514±1.06 0.18
s-Na
+, mEq/L 138.57±4.20 139.09±3.89 137.19±4.77 0.02
s-K
+, mEq/L 05.33±9.98 05.70±11.72 4.01±0.60 0.95
ABGA
pH 07.37±0.15 07.37±0.14 07.36±0.18 0.56
HCO3
-, mmol/L 19.48±6.19 19.75±6.32 18.68±6.09 0.70
Lactate, mmol/L 05.84±7.71 03.80±3.31 07.01±9.45 0.71
Amylase, U/L 51.20±59.82 43.90±33.69 70.67±99.96 0.36
AST, U/L 55.14±101.24 43.19±85.01 91.63±136.11 0.14
ALT, U/L 27.69±25.96 26.63±22.45 31.06±35.45 0.32
LDH, U/L 428.75±296.21 391.98±305.19 553.23±232.28 <0.01
CRP, mg/dL 07.81±8.33 05.00±5.61 15.21±9.92 0.01
Values are presented as mean±SD.
SBP, systolic blood pressure; WBC, white blood cell; Hb, hemoglobin; s-Cr, serum creatinine; ABGA, arterial blood gas analysis; AST, aspar-
tate aminotransferase; ALT, alanine aminotransferase; CRP, C-reactive protein.
a)p-value was calculated by chi-square test and Mann-Whitney U test.
Table 3. Clinical Presentations at Admission (II)
Medical treatment group
(n=60) 
Surgical treatment group
(n=21)
p-value
a)
Heart rate ≥90/min 03 (5.0)  05 (23.8) 0.02
SBP <100 mm Hg  05 (8.3)  07 (33.3)  0.01 
Serum Na
+ <135 mEq/L
b)  07 (11.6) 08 (38.1) 0.01
Serum Cr ≥1.2 mg/dL
b)  13 (21.6) 10 (47.6) 0.04
Serum LDH ≥472 U/L
b)  03 (5.0) 09 (42.8) <0.01
CRP ≥1 mg/dL  25 (41.6)  13 (61.9)  0.08
Values are presented as number (%).
SBP, systolic blood pressure; Cr, creatinine; CRP, C-reactive protein.
a)p-value was calculated by chi-square test; 
b)Cut-off value is upper normal limit used in Chonnam National University Hospital.
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older in surgical treatment group than in medical treatment 
group,
10 although neither in this study nor plenty of reports 
on severity of IC found any statistically significant difference 
in mean age between the two treatment groups.
1,4,7,11-14 Sever-
al study results also reported that IC is a more common dis-
ease in female patients but a poorer prognostic factor in male 
patients. We could not find in this study, however, any statis-
tical difference in gender or frequency between the two 
groups.
7
Patients with history of hypertension, DM, coronary heart 
disease, congestive heart disease, hyperlipidemia and admin-
istration of vasoactive medicine were reported in many stud-
ies to show high frequency of IC incidence. This study also 
found similar pattern with hypertension (29.6%) and DM 
(21.0%) as the most common risk factor, followed by coro-
nary heart disease, liver cirrhosis and cerebrovascular disease 
(n=5, 6.2% each), congestive heart disease (n=2, 2.5%), and 
ESRD (n=1). Studies report, however, different results on 
clinical course of IC according to underlying disease. For in-
stance, studies on contributing factors of clinical course and 
time to admission reported that patients with DM took sta-
tistically longer time before admission.
4 Studies on clinical 
course of chronic renal disease and IC reported that ESRD 
patients on hemodialysis showed severe clinical course re-
quiring surgical treatment and longer mean time to admis-
sion.
14 From 81 IC patients enrolled in this study, only 1 pa-
tient was receiving hemodialysis, who achieved recovery 
after medical treatment. Other underlying diseases also did 
not show any significant difference between medical and 
surgical treatment groups. Serum creatinine level was slightly 
higher in surgical treatment group than in medical treatment 
group, although not statistically significant (1.15±0.89 vs. 
1.51±1.06, p=0.18). The relative risk of patients with in-
creased serum creatinine level above normal range to receive 
surgical treatment was 2.937 (p=0.04), indicating close rela-
tionship between renal function and prognosis in patients 
with symptom development of admission, although we could 
not find prognostic relation between chronic renal disease 
and IC. Such change in renal function index is considered to 
reflect that IC was progressed as a secondary change to dehy-
dration.
15
In the past, barium study was preferred as a diagnostic tool 
for IC. Recently, however, colonoscopy or abdominal CT is 
more commonly selected as a major diagnostic tool. Colo-
noscopy has the advantage that colonoscopist can directly 
observe the colonic mucosa, whereas abdominal CT is good 
when observing bowel wall and abdominal vascular status at 
the same time.
15-17 The medical treatment group in this study 
was diagnosed as IC mostly by colonoscopy (85.0%), where-
as all cases in surgical treatment group received abdominal 
IC scanning and colonoscopy was performed in only 5 cases 
(8.9%). It is speculated that, compared to the medical treat-
ment group showed only mild clinical course, many patients 
in the surgical treatment group showed severe clinical course 
making their general condition unsuitable for colonoscopy.
Symptoms of IC include abdominal pain, vomiting, diar-
rhea, bowel movement change, or hematochezia.
15 Vomiting 
is a risk factor of surgical treatment, but hematochezia was 
reported to be associated with mild clinical course in this 
study, which is comparable to other studies on IC severi-
ty.
1,4,7,11-14,18 This reflects that the degree of colon injury de-
pends on the presence of ischemia, consistent with the fact 
that necrotic colitis patients show vomiting more often than 
non-necrotic colitis patients due to rapid colonic wall full-
thickness necrosis.
19
Surgical treatment group showed high frequency of tachy-
cardia and systolic hypotension at admission, abdominal 
tenderness or rebound tenderness at physical examination, 
and CRP elevation for initial laboratory finding, all indicat-
ing poor prognostic factors. This reflects that rapid inflam-
matory change in IC induced hemodynamic unstability and 
colonic wall full-thickness necrosis as secondary changes, 
suggesting possible progression to bowel perforation and 
peritonitis thereof.
12 Patients who were progressed to colonic 
necrosis or complicated with peritonitis due to the necrosis 
are predicted to show leukocytosis due to inflammation, 
electrolyte or acid-base imbalance due to dehydration, or el-
evation of amylase, AST, or LDL level due to muscle injury. 
Studies actually found hyponatremia or elevated LDH level 
as poor prognostic factors of surgical treatment. This study 
also found hyponatremia or elevated LDH level at admission 
in surgically-treated group, but other laboratory findings was 
not different between the two treatment groups.
12,18
As for the prognosis by involvement site, right lesion was 
generally more common and associated with worse progno-
sis.
7,13 Other domestic reports, however, did not find any sig-
nificant relationship between right colon involvement and 
poor prognosis as this study, which is why further studies are 
required.
There are some limitations in this study. First, being a ret-
rospective analysis, we could not make clear definition about 
medical treatment group and surgical treatment group, or 
identify risk factors such as smoking history or drug history 
affecting vessels of patients. Second, we may not exclude the 
possibility of diagnostic error, because the study relied on 
colonoscopy or abdominal CT scan for the diagnosis of IC 
and did not confirm pathologic findings. Third, we tried to 
find clinical factors associated more with surgical treatment 
than medical treatment, but the sample size was not big 
enough for multivariate analysis and only the univariate 
44-1-07.indd   42 11. 9. 29.   오후 1:35NC Jin et al. 
  43
analysis showed similar result with other studies. Even so, 
this study has implication for being the first report that com-
pared clinical characteristics between medical treatment and 
surgical treatment, and warrants further study with larger 
sample size in the future.
In conclusion, IC patients with initial symptoms such as 
the absence of hematochezia, vomiting, abdominal tender-
ness, abdominal rebound tenderness, tachycardia, systolic 
hypotension, increased serum LDH, creatinine or CRP level 
indicates poor prognosis requiring surgical treatment. When 
patients suspected of IC shows initial clinical factors suggest-
ing poor prognosis requires early aggressive therapy.
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